||
Home Page > Science > Biotherapeutics > Parenterals > Immunoglobulins > Control > Publications

Publications

 

Return to previous page|

Relevant Publications

 

  1. SJ Thorpe and AB Heath.  Development and evaluation of a radioimmunoassay using monoclonal antibodies against Rh D for determining anti-D potency of clinical grade immunoglobulin preparations.  Transfus Med 5, 97-103 (1995).
  2. CE Turner, SJ Thorpe, MDR Brasher and R Thorpe.  Anti-Rh D activity of commercial intravenous immunoglobulin preparations.  Vox Sang 76, 55-58 (1999).
  3. SJ Thorpe, CE Turner, A Heath and D Sands.  A competitive enzyme-linked immunoassay using erythrocytes fixed to microtitre plates for anti-D quantitation in immunoglobulin products.  Vox Sang 79, 100-107 (2000).
  4. C Dolman, SJ Thorpe and R Thorpe.  Enhanced efficacy of anti-D immunoglobulin for treating ITP is not explained by higher immunoglobulin polymer content.  Biologicals 29, 75-79 (2001).
  5. SJ Thorpe, D Sands, G Rautmann and G Schäffner.  International collaborative study to evaluate methods for quantification of anti-D in immunoglobulin preparations.  Vox Sang 83, 42-50 (2002).
  6. SJ Thorpe, B Fox and D Sands.  A stable lyophilized reagent for use in a potential reference assay for quantitation of anti-D in immunoglobulin products.  Biologicals 30, 315-321 (2002).
  7. SJ Thorpe, BJ Fox, CD Dolman, J Lawrence and R Thorpe.  Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.  Vox Sang 85, 80-84 (2003).
  8. SJ Thorpe, D Sands, B Fox, M-E Behr-Gross, G Schäffner and MW Yu.  A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation.  Vox Sang 85, 313-321 (2003).
  9. SJ Thorpe, D Sands, B Fox, G Schäffner, MW Yu and M-E Behr-Gross.  Collaborative study for establishment of a global standard for the potency assay of human anti-D immunoglobulin.  Pharmeuropa Bio 2003-2, 9-26 (2003).
  10. SJ Thorpe, BJ Fox, CD Dolman and R Thorpe.  Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.  Biologicals 33, 111-116 (2005).
  11. SJ Thorpe, B Fox, A Heath, C Dolman, ML Virata, M-Y W Yu and R Thorpe.  International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in IVIG products.  Vox Sang 88, 278-287 (2005).
  12. SJ Thorpe, B Fox, A Heath, M-E Behr-Gross, ML Virata and MW Yu.  International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.  Biologicals 34, 209-212 (2006).
  13. SJ Thorpe, B Fox, A Heath, M-E Behr-Gross, ML Virata and MW Yu.  International collaborative study to establish immunoglobulin (anti-D test) BRP Batch 1.  Pharmeuropa Bio 1, 49-56 (2006).
  14. SJ Thorpe, B Fox, G Sharp, AB Heath, M-E Behr-Gross, E Terao, ML Virata-Theimer and MW Yu.  International collaborative study to evaluate candidate reference reagents to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products.  Vox Sang 97, 160-168 (2009).


Freedom of information | Terms & Conditions | Contact Webmaster
© Health Protection Agency